Although young women often see their obstetrician-gynecologists or primary care physicians for pelvic exams, Pap smears and urinalyses, chlamydia testing is often not performed at the same time, according to study findings published in the May issue of Obstetrics & Gynecology.
Although young women often see their obstetrician-gynecologists or primary care physicians for pelvic exams, Pap smears and urinalyses, chlamydia testing is often not performed at the same time, according to study findings published in the May issue of Obstetrics & Gynecology.
Karen Hoover, MD, and Guoyu Tao, PhD, from the U.S. Centers for Disease Control and Prevention in Atlanta, analyzed data from the 2005 National Ambulatory Medical Care Survey to estimate the prevalence of chlamydia screening among women aged 15 to 25 during visits to obstetrician-gynecologists and primary care physicians.
The researchers found that there were 6.3 million visits to obstetrician-gynecologists and 20.9 million visits to primary care physicians. Obstetrician-gynecologists conducted 68.8% of visits with pelvic examinations and 71.1% of visits with Pap tests, while primary care physicians conducted 77.5% of visits with urinalyses. However, obstetrician-gynecologists did not perform chlamydia testing at 82.1% of visits with pelvic examinations and 77.3% of visits with Pap tests, and primary care physicians did not perform testing at 99.1% of visits with urinalyses, the report indicates.
“There are many missed opportunities for chlamydia testing of young women in ambulatory care visits-during pelvic examinations, Pap tests, and urinalyses,” Hoover and Tao conclude.
Hoover K, Tao G. Missed opportunities for chlamydia screening of young women in the United States. Obstet Gynecol. 2008;111:1097-1102.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More